170 related articles for article (PubMed ID: 36191758)
1. Rationale and Design of the Proactive-HF Trial for Managing Patients With NYHA Class III Heart Failure by Using the Combined Cordella Pulmonary Artery Sensor and the Cordella Heart Failure System.
Guichard JL; Cowger JA; Chaparro SV; Kiernan MS; Mullens W; Mahr C; Mullin C; Forouzan O; Hiivala NJ; Sauerland A; Leadley K; Klein L
J Card Fail; 2023 Feb; 29(2):171-180. PubMed ID: 36191758
[TBL] [Abstract][Full Text] [Related]
2. Twelve-month follow-up results from the SIRONA 2 clinical trial.
Sharif F; Rosenkranz S; Bartunek J; Kempf T; Aßmus B; Mahon NG; Hiivala NJ; Mullens W
ESC Heart Fail; 2024 Apr; 11(2):1133-1143. PubMed ID: 38271076
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of a wireless pulmonary artery pressure sensor: primary endpoint results of the SIRONA 2 clinical trial.
Sharif F; Rosenkranz S; Bartunek J; Kempf T; Assmus B; Mahon NG; Mullens W
ESC Heart Fail; 2022 Oct; 9(5):2862-2872. PubMed ID: 35686479
[TBL] [Abstract][Full Text] [Related]
4. Safety and feasibility of pulmonary artery pressure-guided heart failure therapy: rationale and design of the prospective CardioMEMS Monitoring Study for Heart Failure (MEMS-HF).
Angermann CE; Assmus B; Anker SD; Brachmann J; Ertl G; Köhler F; Rosenkranz S; Tschöpe C; Adamson PB; Böhm M
Clin Res Cardiol; 2018 Nov; 107(11):991-1002. PubMed ID: 29777373
[TBL] [Abstract][Full Text] [Related]
5. Digital health care solution for proactive heart failure management with the Cordella Heart Failure System: results of the SIRONA first-in-human study.
Mullens W; Sharif F; Dupont M; Rothman AMK; Wijns W
Eur J Heart Fail; 2020 Oct; 22(10):1912-1919. PubMed ID: 32476191
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary Artery Pressure-Guided Management of Patients With Heart Failure and Reduced Ejection Fraction.
Givertz MM; Stevenson LW; Costanzo MR; Bourge RC; Bauman JG; Ginn G; Abraham WT;
J Am Coll Cardiol; 2017 Oct; 70(15):1875-1886. PubMed ID: 28982501
[TBL] [Abstract][Full Text] [Related]
7. Interventions Linked to Decreased Heart Failure Hospitalizations During Ambulatory Pulmonary Artery Pressure Monitoring.
Costanzo MR; Stevenson LW; Adamson PB; Desai AS; Heywood JT; Bourge RC; Bauman J; Abraham WT
JACC Heart Fail; 2016 May; 4(5):333-44. PubMed ID: 26874388
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary artery sensor system pressure monitoring to improve heart failure outcomes (PASSPORT-HF): rationale and design of the PASSPORT-HF multicenter randomized clinical trial.
Störk S; Bernhardt A; Böhm M; Brachmann J; Dagres N; Frantz S; Hindricks G; Köhler F; Zeymer U; Rosenkranz S; Angermann C; Aßmus B
Clin Res Cardiol; 2022 Nov; 111(11):1245-1255. PubMed ID: 35246723
[TBL] [Abstract][Full Text] [Related]
9. Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial.
Lindenfeld J; Zile MR; Desai AS; Bhatt K; Ducharme A; Horstmanshof D; Krim SR; Maisel A; Mehra MR; Paul S; Sears SF; Sauer AJ; Smart F; Zughaib M; Castaneda P; Kelly J; Johnson N; Sood P; Ginn G; Henderson J; Adamson PB; Costanzo MR
Lancet; 2021 Sep; 398(10304):991-1001. PubMed ID: 34461042
[TBL] [Abstract][Full Text] [Related]
10. CHAMPION trial rationale and design: the long-term safety and clinical efficacy of a wireless pulmonary artery pressure monitoring system.
Adamson PB; Abraham WT; Aaron M; Aranda JM; Bourge RC; Smith A; Stevenson LW; Bauman JG; Yadav JS
J Card Fail; 2011 Jan; 17(1):3-10. PubMed ID: 21187258
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary artery pressure-guided therapy in ambulatory patients with symptomatic heart failure: the CardioMEMS European Monitoring Study for Heart Failure (MEMS-HF).
Angermann CE; Assmus B; Anker SD; Asselbergs FW; Brachmann J; Brett ME; Brugts JJ; Ertl G; Ginn G; Hilker L; Koehler F; Rosenkranz S; Zhou Q; Adamson PB; Böhm M;
Eur J Heart Fail; 2020 Oct; 22(10):1891-1901. PubMed ID: 32592227
[TBL] [Abstract][Full Text] [Related]
12. Hemodynamic-guided heart-failure management using a wireless implantable sensor: Infrastructure, methods, and results in a community heart failure disease-management program.
Jermyn R; Alam A; Kvasic J; Saeed O; Jorde U
Clin Cardiol; 2017 Mar; 40(3):170-176. PubMed ID: 27878990
[TBL] [Abstract][Full Text] [Related]
13. Ambulatory haemodynamic-guided management reduces heart failure hospitalizations in a multicentre European heart failure cohort.
Dauw J; Sokolski M; Middleton JT; Nijst P; Dupont M; Forouzan O; Rothman AMK; Ruschitzka F; Flammer AJ; Mullens W
ESC Heart Fail; 2022 Dec; 9(6):3858-3867. PubMed ID: 35916354
[TBL] [Abstract][Full Text] [Related]
14. Real-world evidence in a national health service: results of the UK CardioMEMS HF System Post-Market Study.
Cowie MR; Flett A; Cowburn P; Foley P; Chandrasekaran B; Loke I; Critoph C; Gardner RS; Guha K; Betts TR; Carr-White G; Zaidi A; Lim HS; Hayward C; Patwala A; Rogers D; Pettit S; Gazzola C; Henderson J; Adamson PB
ESC Heart Fail; 2022 Feb; 9(1):48-56. PubMed ID: 34882989
[TBL] [Abstract][Full Text] [Related]
15. Recent Advances in Remote Pulmonary Artery Pressure Monitoring for Patients with Chronic Heart Failure: Current Evidence and Future Perspectives.
Clephas PRD; Aydin D; Radhoe SP; Brugts JJ
Sensors (Basel); 2023 Jan; 23(3):. PubMed ID: 36772403
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary Artery Pressure-Guided Heart Failure Management Reduces 30-Day Readmissions.
Adamson PB; Abraham WT; Stevenson LW; Desai AS; Lindenfeld J; Bourge RC; Bauman J
Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27220593
[TBL] [Abstract][Full Text] [Related]
17. Effects of remote haemodynamic-guided heart failure management in patients with different subtypes of pulmonary hypertension: insights from the MEMS-HF study.
Assmus B; Angermann CE; Alkhlout B; Asselbergs FW; Schnupp S; Brugts JJ; Nordbeck P; Zhou Q; Brett ME; Ginn G; Adamson PB; Böhm M; Rosenkranz S
Eur J Heart Fail; 2022 Dec; 24(12):2320-2330. PubMed ID: 36054647
[TBL] [Abstract][Full Text] [Related]
18. Monitoring Pulmonary Arterial Hypertension Using an Implantable Hemodynamic Sensor.
Benza RL; Doyle M; Lasorda D; Parikh KS; Correa-Jaque P; Badie N; Ginn G; Airhart S; Franco V; Kanwar MK; Murali S; Raina A; Agarwal R; Rajagopal S; White J; Biederman R
Chest; 2019 Dec; 156(6):1176-1186. PubMed ID: 31265832
[TBL] [Abstract][Full Text] [Related]
19. Lower Rates of Heart Failure and All-Cause Hospitalizations During Pulmonary Artery Pressure-Guided Therapy for Ambulatory Heart Failure: One-Year Outcomes From the CardioMEMS Post-Approval Study.
Shavelle DM; Desai AS; Abraham WT; Bourge RC; Raval N; Rathman LD; Heywood JT; Jermyn RA; Pelzel J; Jonsson OT; Costanzo MR; Henderson JD; Brett ME; Adamson PB; Stevenson LW;
Circ Heart Fail; 2020 Aug; 13(8):e006863. PubMed ID: 32757642
[TBL] [Abstract][Full Text] [Related]
20. Enhanced External Counterpulsation (EECP): An Evidence-Based Analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(5):1-70. PubMed ID: 23074496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
